REMINDER: Our user survey closes on Friday, please submit your responses here.
In my view the BOD have DELIBERATELY witheld pertinent Financial information regarding the launch etc. As JB said himself in the VERY recent Investor presentation, he is legally required to release pertinent information of this nature. As such I think the BOD have hidden behind so-called Confidentiality Agreements to keep the SP low until they can get their options sorted. I think this is utterly wrong so have this morning filed a formal compliant with the Financial Services to have this conduct investigated.
The BOD deserve to be penalised if they act like this.
Just goes to show that their body language in the presentation truly reflected their utter indifference to shareholders.
RNs statement:
"Futura Medical Chief Executive Officer James Barder said: "I am delighted to be reporting on this landmark set of results..."
Me thinks we werer all watching a different Video. It was nothing short of hugely disappointing. Sorry, you can all say I'm wrong or being negative etc but it's clear that the BOD has no intention of giving Private Shareholders any information to make any form of investment decision.
Simply saying their hands are commercially or legally tied etc is passing the buck.
And trying to persuade anyone to simply "bear with us" is NOT the statement of a confident, professional company approach.
We don't even have any idea of what the future product rangee is or what they are actually working on. All hush hush, can't give away infor to competitors etc.
This is actually the worst company shareholder presentation I have ever seen - bare none.
Couldn't agree more that it was an incredibly frustrating presentation.
Forstly, Kames Barder' body language of continuously looking out the window while speaking was very off-putting as it gave the impresioon that he actually wasn't interested (yes I know he's simply 'contemplating' his responses etc) but it gives a very negative impression.
THe biggest issue is they would not give any idea of future projected income. Yes we all know its not possible for them to disclose commercial information etc. But they only gave 'projected' figures for the Us market then left it to us to try to figure out what that means for the entire world marlet (excluding China of course).
FUM have stated that tthey beleivee they will be "Net Positive" by 2025. Yet were unabel to give a projected gross income figure to support this statement.
They MUST have alculated their projected income stream againsst future spend to arrive at this 'formal' Net-Positive statement. SO why can't they provide their projected income estimates?
As an LTI I am very disappointed in thhis presentation as it gives me absolutely no clue as to the future potential revenue or anything else.
It wa just a "wash-out".
I'm not surprised the SP has dropped so savagely by over 16%
Sorry, but had to put a "Strong Sell" for today's useless presentation.
I've been monitoring this share thinking it might be worth a punt.
But reading the february rns gives me the impression Capricorn is truly scuppered.
1) the storage facility won't be in place, constructed and fully tested & certified until at least another month or 2 (looking may at best)
2) woodside have absolutely no incentive to achieve the 72hr continuous production and 30,000 barrells of 'saleable' oil. In fact, it is in Woodside' best interests to avoid it by the june deadline as then rhey don't lose in paying out minimum £25M to Capricorn.
3) I might be 'nieve' but..... if I was Woodside i could easily run production for 70hrs, shutdown, restart after 1 hr.... "rinse & repeat'. Capricorn can't do a damn thing about it.
4) the likelyhood of the Senegal government giving in to rescinding the £25M tax+interest+penalties is seriously doubtful. At best Capricorn will have to take it through the international courts... costing millions with little hope of success.
5) The government will (imho) immediately 'arrest' any £25M+ tax etc from Woodside if they were to meet the production deadline. Woodside would have no choice in the matter. Partly because the government will likely threaten their production license, but mostly because the government will establish it as a "Priority One" debt..... just as the UK government and any other government does.
So, my question is this..... how the Hell is Capricorn going to get over all those hurdles?
What are their plans to even negate any of the above?
Note: any 'contract', guarantee etc with Woodside for payments etc is legally null & void if (aka when) the government claims a Priority 1 debt.
Clearly many rampers etc will 'attack' my post for being negative etc.
But the fact is that the Sales Team are clearly incompetent if they can only get such a low sales figure after all this time.
You can all go on about it takes time to introduce things into medical processes etc but the fact is that this should have progressed much more rapidly than this for sales.
And for any responders... i'ce been a long term invextor but seldom if ever commented on this particular board. But enough is enough.
.time to actualky replace the Sales Team or license it completely out.
So time for BOD to stoo "topping-Up" their bonuses etc and getting far more serious about pushing things forward.
You cannot simply rely on a product being good to sell itself.
Its a bad shake at present!
Disgusting MM behaviour as usual and should be stopped. But we're just PIs.
On the positive side, the RNS states ".... sustained profitability by 2025...".
To use the term 'sustained' means consecutive positive results. so this is a clear mssage that they expect to become cash/revenue positive in 2024 in order to sustain it into 2025 :-) :-) :-)
So time to hold and by during the 'shake-out'.
DarthInvestor: I'm already heavy on Fum in my portfolio. I'm almost £50k invested thus far, so hopefully that gives a clue how good I think the future is.
The share market is extremely difficult to call at present and for the next 6 months and I've decided that FUM provides one of the few 'guaranteed' double digit+ returns in the next 6 months.
So FUM is one of those shares I've invested heavily in on the basis that I'm happy to sit back and wait for a very good return.
I seldom ever listen to trolls who try to ramp shares and claim multibagger capabilities.
But.... FUM (imho) is now one of the few I actually think will double my investment within a year.
So, I'm happy to wait up to 12 months to make £50k+ profit.
And shall be topping up regularly.
Really hoping this will prove my loyalty as an actual long term investor.
P.S. as always "STRONG, STRONG BUY"
Gla
Henners: By all means make stupid remarks on other peoples comments such as mine.
there is absolutely nothing wrong with my figures. They correlate with all the previous RNS figures.
If you think they are wrong then why don't you ACTUALLY wirte down the corrected figured rather than simply trying to 'imply' I, or anyone else is wrong.
You seem to think I am somehow 'rubbishingn' FUM. Yet my comment is FAR FROM IT. It is actually saying that the Full Year REport is going to be the Real Story of just how well the company has done.
I even propose that they will become net positive.
So get you own facts straight and stop trying to Troll others.
By all means if you don't like what I say...... then filter me.
P.S. You 'mightt' even notivve that I mark my opinion as £Strong Buy" on all my posts ...... IDIOT!
The upcoming Interim Results up to June 2023 will liley 'disappoint' a few.
I project that there nay be some indication of a reduction in the 'net' Burn down, but the Final Results in June next year are where we are likely to see a move into Net Return.
However, the outlook for the Interims will definitely set the scene and I think the BOD will definitely want to paint the best possible Positive Guidance for the full results.
Most of the 'enthusiam' is based around the US marketability. We are unlikely to see any income from European sales for interim period. Sales are only in latter half.
The only viable income may be for the 'Undiclosed initial Payment' from Cooper et al. However, we don't know what that is. The US agreement has an initial £4m up front payment which won't show up aas they will likely be paid/captured in Latter half.
The Cash burn for 2022 was £6.34M. So, if they do get a £1M payment from Cooper then this may bring their interim cash burn to arround the £3M mark. i.e. I expect their cash burn to increase for the 2023 period as I suspect they will have greater outlays/payments relating to marketing activities.
I don't think we will see any sales figures as they would only be 'projected' figures.
The BIG footnote will be a statement or 2 added regarding the current and future sales figures //// since June 2023.
This isn't normally captured as they are future events. But it would be prudent for the Board to give shareholders/market some 'guidance' as to the expected/projected outcome for the full year.
In my view the Full Results will be extremely positive.
FM have the £4M initial payment from US Market.
They may include the Cooper initial payment in the full results as I suspect Cooper would not have paid it before June'23. So possible £1-2M.
Milestone payments are very 'sketchy' as the Cooper payments are 'undisclosed. while the US payments are £5M-£45M over 'several' years (just exactly what is meant by 'several' years). Worst case scenario it is the 5 Year deal period so milestone payments will be in £1M-£5M per annum.
Assuming £1-2M Milestone payments in the full year, this gives FM an income projection around £6M to £7M+.
So, This implies a 'potential' Net Profit declared in the Full results of around £0.5M-£1M+.
Anything above this is extremely positive.
IMHO
I'm pointing out the fact that there is little info about actual 'Royalty' conditions.
Having negotiated Royalites for IPR etc myself (yes Bandit1 I actually do know about this stuff!) the Royalties can be exceedling small.
Also, the Royalty conditions can haave a marked effect on the actual incom revenue. Such as whether royalty percentage is paid on gross sale or net after Seller removes ALL overheads.
Such conditions can render Royalt payments almost non-existent.
So, until an RNS comes out as to 'whaat' the Royalty' payment terms are AND we get a figure of the sales etc, we don't have a clue as to what the future income stream actually is at all.
So, yes the RNS doesn't give us much clue. If FUM is only getting 5% of NET sales revenue (after all costs etc) then that won't actually be that much.
Haleon definitely has the better deal.... unless FUM release more detailed information.
Bandit1: You're talking utter rubbish and trying to troll my comment. It's clear from your repvious posts that you do nothing more than htpe up the share and trash anyone who has an opposing viewpoint. So from now on its best everyone just filters you, as I am now doing.
By the way I haven't sold - yet. Just goes to show you are nothing more than a TRoll :-)
By all meaans filter me if my comments offend you soooooo much.
As a long term investor, and having recently topped up with the previous drop, I haave to say that I'm a little disappointed with the Haleon deal to be honest.
Looking at the Royalty figures quoted, it is unclear what is meant by the term ".... over several years....". THat could be anyting between 2...5+ years.
Also, the proposed Royalty income is actually very small given all the hype about how big the market could be and how FUM have a 'singular' OTC product.
The figures of between £5M-£45M over several years could mean 'maximium' royalties of £2.5M to £22M+ if we ssume onyl 2 years.
But the explicit use of the term ".... several years...." appears to have bene 'carefully' cohsoen and I suspect means 3+years.
So FUM could really only be looking at between a 'Maximum' £12M-£15M+ per year. Which is quite frankly small change given the potential market.
I have to say thhat I think Haleon have defontivly got the better part of the deal.
So I don't see how this is going to push up FUM SP to any great degree. Certainly seems difficult to see how it can be pushed above £1 in any short-term period (1-2 years).
But you neveer know, I could be wrong. Anyone have any idea how an income stream of £12-£15m per annum will have an effect on FUM' PERatio etc ?
I do'nt see a dividend out of this as some are hoping. (imho)
So much for the ramping of the benefits of OTC presence.
Certainly shows how much the BOD and other rampers think the OTC presence is such a 'wonderful' thing for GENF eh.
there's absoultely NO interest in GENFF shares. An absolute, Abject failure.
I suspect US investors have looked at the UK SP and taken into account the Exchange rate to come up with the idea that the original OTC float valuations were well and truly far over-inflated.
So it's finally come home to roost that things are NOT going to happen positively for either SP unless the BOD and show any ACTUAL real-world progress in any of its projects etc.
I suspect this will be languishing down here for some years to come....with the occasional 'spike' by Market Manipulators.... such as hte ones arrested recently and clearly involved with GENF.
Time to bail out.... much better prospects elsewhere.... bye bye
Disagree. It looks like there are Bids and Offers being lodged but no takers.
And I can see why.......
Yesterday the Ask/Offer was 0.01 / 0.1. Today it is 0.02 / 0.08. 400%+
they are absolutely ridiculous spreads. No one in their right mind is going to trade on those spread terms.
Hence I don't see this trading at all until the spread reduces well below 30-40%.
I don't know why the GENF BOD either agreed to such leverage or whether they have "pie-in-the-sky" ambitions. But they are not helping. THey should go back to the 'Book' and demand some form of 'resolution to get the GENFF shares into a 'viable' Liquidity state.
IMHO :-)
P.S. Sorry about all the typos in last message. I have a damaged Rotator Cuff and making it very painful to type :-)
Lilw: THanks for feedback. I agree with everything you say. It's just strange that there is no trading whatsoever.
The important info I (and everyone else probably) don't have is what was the Pre-IPO share value on the OTC?
If those involved in holding the initial Stock are working off the basis that it was 'Over-priced' compared to the UK-SP it may be that Us investors are standing back and waiting for tthe US Offer price to decline to better match the UK-SP.
Whereas, of course, we in the UK want the reverse ha ha
I guess we are ALL waiting with baited breath for when that FIRST trade(s) appear on the OTC and we can then see what's happening.
Anyway, good luck everyone
It's actaully scary that there is NO TRADING whatsever on OTC.
Even with 'limited' press announcements etc you would still expect there to be 'some
level of trading for a new stock. So not sure if there is any 'stock' actually available to trade???
I don't see how OTC market is going to help the UK SP rating to be honst. It's all pie-in-the-sky...... and troubling that there is not a dicky bird happening.
Clearly those of you opposed to my comment regarding the predicament that this company is in shows a lack of intellect and a desire to try to bolster support from new investors.
the fact is that the BOD themselves have CLEARLY indicated that the company faces a VERY REAL RISK of not being able to remian a going concern.
Let's face it they burn through over £9M in cash with a pitence of £220K return. that won't even cover half the Director' salary and son't forgt that the BOD are STILL giving themselves handouts in the form of share bonuses etc.
The company is simply a Cash Cow for the BOD at this stage.
If you can't see the writing on the wall then that's your problem.
But the fact remains that this company CANNOT and WILL NOT be in any way Cash Positive for the forseeable future..... and I suspect they will be selling the company on at a large discount.
When the BOD DO SELL the assets, you can bet your last pennies that the BOD will gain a nice bonus as part of the sale. While all the PIs are left with egg on their face.
You have been warned..... don't come crying when the inevitable happens. As for me, I'm well out and staying out,.... but going to watch on the side lines so when this goes down the drain I can make some great comments and re-post some of your posts so people can see you for what you are.
Ther is NOTHING exciting' or good on the horizon as some Users seem to be saying about OBD.
Please RED the RNS. THe company has made it ABUNDANTLY clear that there is SIGNFICANT concern that the ability to remain a going concern is in great doubt.
They have NO PROJECTED income stream, the little they did get of £220k is a pittence compard to their £9M+ cash burn.
The fact is that they cannot raise such high income given their product unless a miracle occurs.
they will DEFINITELY have ot raise further cash within 6 months given lack of resources. So all in all it looks like OBD is going to have to shut up shop...... unless a miracle occurs.
Sorry, but the RNS clearly indicates what is going to happen. Even a further one or two cash raises is not going to resolve the underlying lack of foreseable major income.
Andy96: there's two aspects to the 'cash' question that needs to be considered.
Firstly, the Yahoo article by itself is 'correct' regarding the risk of cash burn-through and hence need to raise.
Secondly, yes FUM have stated that cash level extends into Eroxon launch.
But, the Yahoo article ignores anyy potential revenu while the FUm statementvgives no clue as to when they can expect any revenu.
So we as investors are left with a bit of a grey area as to whether FUM can gain sufficient revenu via an ongiong basis to staive off any cash raise.
We all hope that FUM will announce (sooner than later) when revenue is likely and how much and timescales.
Also a confirmation that they WON'T need to raise funds by other means.
On the bright side. I have no doubt revenue will trickle in to prevent any raise and future revenue will increase to push market value.
Hence my "Strong Buy" opinion.